Impaired FXR‐CPT1a signaling contributes to parenteral nutrition‐induced villus atrophy in short‐bowel syndrome

Parenteral nutrition (PN)‐induced villus atrophy is a major cause of intestinal failure (IF) for children suffering from short bowel syndrome (SBS), but the precise mechanism remains unclear. Herein, we report a pivotal role of farnesoid X receptor (FXR) signaling and fatty acid oxidation (FAO) in PN‐induced villus atrophy. A total of 14 pediatric SBS patients receiving PN were enrolled in this study. Those patients with IF showed longer PN duration and significant intestinal villus atrophy, characterized by remarkably increased enterocyte apoptosis concomitant with impaired FXR signaling and decreased FAO genes including carnitine palmitoyltransferase 1a (CPT1a). Likewise, similar changes were found in an in vivo model of neonatal Bama piglets receiving 14‐day PN, including villus atrophy and particularly disturbed FAO process responding to impaired FXR signaling. Finally, in order to consolidate the role of the FXR‐CPT1a axis in modulating enterocyte apoptosis, patient‐derived organoids (PDOs) were used as a mini‐gut model in vitro. Consequently, pharmacological inhibition of FXR by tauro‐β‐muricholic acid (T‐βMCA) evidently suppressed CPT1a expression leading to reduced mitochondrial FAO function and inducible apoptosis. In conclusion, impaired FXR/CPT1a axis and disturbed FAO may play a pivotal role in PN‐induced villus atrophy, contributing to intestinal failure in SBS patients.